TGF-β in tolerance, development and regulation of immunity

Cellular Immunology

Volumn 299, Issue , 2016, Pages 14-22

  Johnston, Chris J C ^a   Smyth, Danielle J ^a   Dresser, David W ^a   Maizels, Rick M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Infection; Tolerance; Transforming growth factor; Transplantation

Indexed keywords

CD4 ANTIGEN; IMMUNOGLOBULIN A; TRANSFORMING GROWTH FACTOR BETA;

ADOPTIVE TRANSFER; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; GENE CONTROL; GENETIC TRANSCRIPTION; GRAFT SURVIVAL; HELMINTH; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFECTION; NONHUMAN; PARASITE IMMUNITY; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROCESSING; REGULATORY T LYMPHOCYTE; SEX DETERMINATION; SEX DIFFERENTIATION; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; BOVINE; COMMUNICABLE DISEASE; GENETICS; IMMUNOLOGY;

ANIMALS; CATTLE; COMMUNICABLE DISEASES; HELMINTHS; HUMANS; IMMUNE TOLERANCE; MODELS, IMMUNOLOGICAL; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84947983240     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2015.10.006     Document Type: Article

References (145)

1. [1] Massagué, J., The TGF-β family of growth and differentiation factors. Cell 49 (1987), 437–438.
2. [2] Massagué, J., The transforming growth factor-β family. Annu. Rev. Cell Biol. 6 (1990), 597–641.
3. [3] Johnson, A.N., Newfeld, S.J., The TGF-β family: signaling pathways, developmental roles, and tumor suppressor activities. Sci. World J. 2 (2002), 892–925.
4. [4] Huminiecki, L., Goldovsky, L., Freilich, S., Moustakas, A., Ouzounis, C., Heldin, C.H., Emergence, development and diversification of the TGF-β signalling pathway within the animal kingdom. BMC Evol. Biol., 9, 2009, 28.
5. + regulatory T cells. J. Mol. Cell Biol. 4 (2012), 29–37.
6. [6] Attisano, L., Wrana, J.L., Signal transduction by the TGF-β superfamily. Science 296 (2002), 1646–1647.
7. [7] Lönn, P., Moren, A., Raja, E., Dahl, M., Moustakas, A., Regulating the stability of TGFβ receptors and Smads. Cell Res. 19 (2009), 21–35.
8. [8] Taylor, A.W., Review of the activation of TGF-β in immunity. J. Leukoc. Biol. 85 (2009), 29–33.
9. [9] Shi, Y., Massagué, J., Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113 (2003), 685–700.
10. [10] Worthington, J.J., Klementowicz, J.E., Travis, M.A., TGFβ: a sleeping giant awoken by integrins. Trends Biochem. Sci. 36 (2011), 47–54.
11. [11] Bader, B.L., Rayburn, H., Crowley, D., Hynes, R.O., Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all αv integrins. Cell 95 (1998), 507–519.
12. 8 on dendritic cells causes autoimmunity and colitis in mice. Nature 449 (2007), 361–365.
13. [13] Derynck, R., Zhang, Y.E., Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425 (2003), 577–584.
14. [14] Yan, X., Lin, Z., Chen, F., Zhao, X., Chen, H., Ning, Y., Chen, Y.G., Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-β signaling. J. Biol. Chem. 284 (2009), 30097–30104.
15. [15] Savage, C., Das, P., Finelli, A.L., Townsend, S.R., Sun, C.-Y., Baird, S.E., Padgett, R.W., Caenorhabditis elegans genes sma-2, sma-3 and sma-4 define a conserved family of transforming growth factor β pathway components. Proc. Natl. Acad. Sci. U.S.A. 93 (1996), 790–794.
16. [16] Raftery, L.A., Sutherland, D.J., TGF-β family signal transduction in Drosophila development: from Mad to Smads. Dev. Biol. 210 (1999), 251–268.
17. [17] Beall, M.J., McGonigle, S., Pearce, E.J., Functional conservation of Schistosoma mansoni Smads in TGF-β signaling. Mol. Biochem. Parasitol. 111 (2000), 131–141.
18. [18] Loverde, P.T., Osman, A., Hinck, A., Schistosoma mansoni: TGF-β signaling pathways. Exp. Parasitol. 117 (2007), 304–317.
19. + T regulatory cells and prolongs skin-graft survival in murine models. Int. Immunopharmacol., 2015.
20. [20] Monteleone, G., Boirivant, M., Pallone, F., MacDonald, T.T., TGF-beta1 and Smad7 in the regulation of IBD. Mucosal Immunol. 1:Suppl. 1 (2008), S50–53.
21. [21] Xu, P., Bailey-Bucktrout, S., Xi, Y., Xu, D., Du, D., Zhang, Q., Xiang, W., Liu, J., Melton, A., Sheppard, D., Chapman, H.A., Bluestone, J.A., Derynck, R., Innate antiviral host defense attenuates TGF-beta function through IRF3-mediated suppression of Smad signaling. Mol. Cell 56 (2014), 723–737.
22. [22] Onichtchouk, D., Chen, Y.G., Dosch, R., Gawantka, V., Delius, H., Massague, J., Niehrs, C., Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature 401 (1999), 480–485.
23. [23] Gu, A.D., Wang, Y., Lin, L., Zhang, S.S., Wan, Y.Y., Requirements of transcription factor Smad-dependent and -independent TGF-β signaling to control discrete T-cell functions. Proc. Natl. Acad. Sci. U.S.A. 109 (2012), 905–910.
24. [24] Thiery, J.P., Acloque, H., Huang, R.Y., Nieto, M.A., Epithelial-mesenchymal transitions in development and disease. Cell 139 (2009), 871–890.
25. + T helper cells engineered to produce latent TGF-b1 reverse allergen-induced airway hyperreactivity and inflammation. J. Clin. Invest. 105 (2000), 61–70.
26. + T cells through TGF-b-TGF-b receptor interactions in type 1 diabetes. Proc. Natl. Acad. Sci. U.S.A. 100 (2003), 10878–10883.
27. [27] Kulkarni, A.B., Huh, C.-G., Becker, D., Geiser, A., Lyght, M., Flanders, K.C., Roberts, A.B., Spron, M.B., Ward, J.M., Karlsson, S., Transforming growth factor b1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. U.S.A. 90 (1993), 770–774.
28. [28] Gorelik, L., Flavell, R.A., Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12 (2000), 171–181.
29. [29] Li, M.O., Wan, Y.Y., Sanjabi, S., Robertson, A.K., Flavell, R.A., Transforming growth factor-β regulation of immune responses. Annu. Rev. Immunol. 24 (2006), 99–146.
30. [30] Coffman, R.L., Lebman, D.A., Shrader, B., Transforming growth factor β specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J. Exp. Med. 170 (1989), 1039–1044.
31. [31] Sonoda, E., Matsumoto, R., Hitoshi, Y., Ishii, T., Sugimoto, M., Araki, S., Tominaga, A., Yamaguchi, N., Takatsu, K., Transforming growth factor β induces IgA production and acts additively with interleukin 5 for IgA production. J. Exp. Med. 170 (1989), 1415–1420.
32. [32] Pang, Y., Gara, S.K., Achyut, B.R., Li, Z., Yan, H.H., Day, C.P., Weiss, J.M., Trinchieri, G., Morris, J.C., Yang, L., TGF-β signaling in myeloid cells is required for tumor metastasis. Cancer Discov. 3 (2013), 936–951.
33. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198 (2003), 1875–1886.
34. + regulatory T cells responsible for protection against diabetes. Proc. Natl. Acad. Sci. U.S.A. 101 (2004), 4572–4577.
35. [35] Daley, S.R., Ma, J., Adams, E., Cobbold, S.P., Waldmann, H., A key role for TGF-beta signaling to T cells in the long-term acceptance of allografts. J. Immunol. 179 (2007), 3648–3654.
36. [36] Chauhan, S.K., Saban, D.R., Lee, H.K., Dana, R., Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J. Immunol. 182 (2009), 148–153.
37. [37] Williams, L.M., Rudensky, A.Y., Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8 (2007), 277–284.
38. [38] Regateiro, F.S., Howie, D., Nolan, K.F., Agorogiannis, E.I., Greaves, D.R., Cobbold, S.P., Waldmann, H., Generation of anti-inflammatory adenosine by leukocytes is regulated by TGF-beta. Eur. J. Immunol. 41 (2011), 2955–2965.
39. H17 lineage. Nature 441 (2006), 231–234.
40. − effector T cells. Nat. Immunol. 9 (2008), 1347–1355.
41. [41] Sakaguchi, S., Yamaguchi, T., Nomura, T., Ono, M., Regulatory T cells and immune tolerance. Cell 133 (2008), 775–787.
42. [42] Josefowicz, S.Z., Lu, L.F., Rudensky, A.Y., Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30 (2012), 531–564.
43. [43] Abbas, A.K., Benoist, C., Bluestone, J.A., Campbell, D.J., Ghosh, S., Hori, S., Jiang, S., Kuchroo, V.K., Mathis, D., Roncarolo, M.G., Rudensky, A., Sakaguchi, S., Shevach, E.M., Vignali, D.A., Ziegler, S.F., Regulatory T cells: recommendations to simplify the nomenclature. Nat. Immunol. 14 (2013), 307–308.
44. + regulatory T cells. J. Exp. Med. 201 (2005), 1061–1067.
45. [45] Brunkow, M.E., Jeffery, E.W., Hjerrild, K.A., Paeper, B., Clark, L.B., Yasayko, S.A., Wilkinson, J.E., Galas, D., Ziegler, S.F., Ramsdell, F., Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27 (2001), 68–73.
46. [46] Bennett, C.L., Christie, J., Ramsdell, F., Brunkow, M.E., Ferguson, P.J., Whitesell, L., Kelly, T.E., Saulsbury, F.T., Chance, P.F., Ochs, H.D., The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27 (2001), 20–21.
47. [47] Bacchetta, R., Passerini, L., Gambineri, E., Dai, M., Allan, S.E., Perroni, L., Dagna-Bricarelli, F., Sartirana, C., Matthes-Martin, S., Lawitschka, A., Azzari, C., Ziegler, S.F., Levings, M.K., Roncarolo, M.G., Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J. Clin. Invest. 116 (2006), 1713–1722.
48. [48] Roychoudhuri, R., Eil, R.L., Restifo, N.P., The interplay of effector and regulatory T cells in cancer. Curr. Opin. Immunol. 33 (2015), 101–111.
49. [49] Maizels, R.M., Smith, K.A., Regulatory T cells in infection. Adv. Immunol. 112 (2011), 73–136.
50. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389 (1997), 737–742.
51. [51] Collison, L.W., Chaturvedi, V., Henderson, A.L., Giacomin, P.R., Guy, C., Bankoti, J., Finkelstein, D., Forbes, K., Workman, C.J., Brown, S.A., Rehg, J.E., Jones, M.L., Ni, H.T., Artis, D., Turk, M.J., Vignali, D.A., IL-35-mediated induction of a potent regulatory T cell population. Nat. Immunol. 11 (2010), 1093–1101.
52. [52] Regateiro, F.S., Howie, D., Cobbold, S.P., Waldmann, H., TGF-β in transplantation tolerance. Curr. Opin. Immunol. 23 (2011), 660–669.
53. [53] Hegner, B., Schaub, T., Dragun, D., Editorial: triple-agent TGF-beta. J. Leukoc. Biol. 93 (2013), 459–462.
54. [54] Ghoreschi, K., Laurence, A., Yang, X.P., Tato, C.M., McGeachy, M.J., Konkel, J.E., Ramos, H.L., Wei, L., Davidson, T.S., Bouladoux, N., Grainger, J.R., Chen, Q., Kanno, Y., Watford, W.T., Sun, H.W., Eberl, G., Shevach, E.M., Belkaid, Y., Cua, D.J., Chen, W., O'Shea, J.J., Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling. Nature 467 (2010), 967–971.
55. [55] Zhou, L., Lopes, J.E., Chong, M.M., Ivanov, I.I., Min, R., Victora, G.D., Shen, Y., Du, J., Rubtsov, Y.P., Rudensky, A.Y., Ziegler, S.F., Littman, D.R., TGF-b-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORgt function. Nature 453 (2008), 236–240.
56. [56] Leng, Q., Bentwich, Z., Borkow, G., Increased TGF-beta, Cbl-b and CTLA-4 levels and immunosuppression in association with chronic immune activation. Int. Immunol. 18 (2006), 637–644.
57. [57] Turner, J.D., Jackson, J.A., Faulkner, H., Behnke, J., Else, K., Kamgno, J., Boussinesq, M., Bradley, J.E., Intensity of intestinal infection with multiple worm species is related to regulatory cytokine output and immune hyporesponsiveness. J. Infect. Dis. 197 (2008), 1204–1212.
58. h2 shift. Int. Immunol. 12 (2000), 623–630.
59. [59] King, C.L., Mahanty, S., Kumaraswami, V., Abrams, J.S., Regunathan, J., Jayaraman, K., Ottesen, E.A., Nutman, T.B., Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J. Clin. Invest. 92 (1993), 1667–1673.
60. [60] Mahanty, S., Nutman, T.B., Immunoregulation in human lymphatic filariasis: the role of interleukin 10. Parasite Immunol. 17 (1995), 385–392.
61. + regulatory T cells in mice infected with the filarial parasite, Brugia malayi. J. Immunol. 181 (2008), 6456–6466.
62. + regulatory T cells in Heligmosomoides polygyrus infection. Eur. J. Immunol. 37 (2007), 1874–1886.
63. [63] Rausch, S., Huehn, J., Kirchhoff, D., Rzepecka, J., Schnoeller, C., Pillai, S., Loddenkemper, C., Scheffold, A., Hamann, A., Lucius, R., Hartmann, S., Functional analysis of effector and regulatory T cells in a parasitic nematode infection. Infect. Immun. 76 (2008), 1908–1919.
64. [64] Smith, K.A., Filbey, K.J., Reynolds, L.A., Hewitson, J.P., Harcus, Y., Boon, L., Sparwasser, T., Hämmerling, G., Maizels, R.M., Low level regulatory T cell activity is essential for functional type-2 effector immunity to expel gastrointestinal helminths. Mucosal Immunol., 2015.
65. + regulatory T cells that interfere with immune response and parasite clearance in BALB/c mice. J. Immunol. 186 (2011), 4295–4305.
66. [66] Grainger, J.R., Smith, K.A., Hewitson, J.P., McSorley, H.J., Harcus, Y., Filbey, K.J., Finney, C.A.M., Greenwood, E.J.D., Knox, D.P., Wilson, M.S., Belkaid, Y., Rudensky, A.Y., Maizels, R.M., Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway. J. Exp. Med. 207 (2010), 2331–2341.
67. [67] Maizels, R.M., Lawrence, R.A., Immunological tolerance: the key feature in human filariasis?. Parasitol. Today 7 (1991), 271–276.
68. [68] King, C.L., Kumaraswami, V., Poindexter, R.W., Kumari, S., Jayaraman, K., Alling, D.W., Ottesen, E.A., Nutman, T.B., Immunologic tolerance in lymphatic filariasis. Diminished parasite-specific T and B cell lymphocyte precursor frequency in the microfilaremic state. J. Clin. Invest. 89 (1992), 1403–1410.
69. [69] Barthlott, T., Kassiotis, G., Stockinger, B., T cell regulation as a side effect of homeostasis and competition. J. Exp. Med. 197 (2003), 451–460.
70. [70] Doligalska, M., Rzepecka, J., Drela, N., Donskow, K., Gerwel-Wronka, M., The role of TGF-β in mice infected with Heligmosomoides polygyrus. Parasite Immunol. 28 (2006), 387–395.
71. [71] Ince, M.N., Elliott, D.E., Setiawan, T., Metwali, A., Blum, A., Chen, H.L., Urban, J.F., Flavell, R.A., Weinstock, J.V., Role of T cell TGF-β signaling in intestinal cytokine responses and helminthic immune modulation. Eur. J. Immunol. 39 (2009), 1870–1878.
72. + regulatory T cells develop, but exuberant IFN-γ production renders mice more susceptible to helminth infection. J. Immunol. 189 (2012), 1113–1117.
73. [73] Heitmann, L., Rani, R., Dawson, L., Perkins, C., Yang, Y., Downey, J., Holscher, C., Herbert, D.R., TGF-beta-responsive myeloid cells suppress type 2 immunity and emphysematous pathology after hookworm infection. Am. J. Pathol. 181 (2012), 897–906.
74. [74] Elias, D., Britton, S., Aseffa, A., Engers, H., Akuffo, H., Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-β production. Vaccine 26 (2008), 3897–3902.
75. [75] Aranzamendi, C., Fransen, F., Langelaar, M., Franssen, F., van der Ley, P., van Putten, J.P., Rutten, V., Pinelli, E., Trichinella spiralis secreted products modulate DC functionality and expand suppressive regulatory T cells in vitro. Parasite Immunol. 34 (2012), 210–223.
76. [76] Zaccone, P., Burton, O., Miller, N., Jones, F.M., Dunne, D.W., Cooke, A., Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice. Eur. J. Immunol. 39 (2009), 1098–1107.
77. + T cells. Eur. J. Immunol. 41 (2011), 2709–2718.
78. [78] Korten, S., Kaifi, J.T., Büttner, D.W., Hoerauf, A., Transforming growth factor-β expression by host cells is elicited locally by the filarial nematode Onchocerca volvulus in hyporeactive patients independently from Wolbachia. Microbes Infect. 12 (2010), 555–564.
79. [79] Li, N., Ren, A., Wang, X., Fan, X., Zhao, Y., Gao, G.F., Cleary, P., Wang, B., Influenza viral neuraminidase primes bacterial coinfection through TGF-β-mediated expression of host cell receptors. Proc. Natl. Acad. Sci. U.S.A. 112 (2015), 238–243.
80. [80] Gomez-Escobar, N., Lewis, E., Maizels, R.M., A novel member of the transforming growth factor-β (TGF-β) superfamily from the filarial nematodes Brugia malayi and B. pahangi. Exp. Parasitol. 88 (1998), 200–209.
81. [81] Gomez-Escobar, N., Gregory, W.F., Maizels, R.M., Identification of Bm-tgh-2, a filarial nematode homolog of C. elegans daf-7 and human TGF-b, expressed in microfilarial and adult stages of Brugia malayi. Infect. Immun. 68 (2000), 6402–6410.
82. [82] McSorley, H.J., Grainger, J.R., Harcus, Y.M., Murray, J., Nisbet, A., Knox, D.P., Maizels, R.M., Daf-7-related TGF-β homologues from trichostrongyloid nematodes show contrasting life cycle expression patterns. Parasitology 137 (2010), 159–171.
83. [83] Korten, S., Buttner, D.W., Schmetz, C., Hoerauf, A., Mand, S., Brattig, N., The nematode parasite Onchocerca volvulus generates the transforming growth factor-beta (TGF-beta). Parasitol. Res. 105 (2009), 731–741.
84. [84] Freitas, T., Jung, E., Pearce, E.J., TGF-b signaling controls embryo development in the parasitic flatworm Schistosoma mansoni. PLoS Pathog., 3, 2007, e52.
85. [85] Freitas, T.C., Jung, E., Pearce, E.J., A bone morphogenetic protein homologue in the parasitic flatworm, Schistosoma mansoni. Int. J. Parasitol. 39 (2009), 281–287.
86. [86] Nono, J.K., Immunomodulation through Excretory/Secretory Products of the Parasitic Helminth Echinococcus multilocularis. 2015, Julius-Maximilians-Universität Würzburg, Würzburg.
87. + induced regulatory T cells. J. Immunol. 182 (2009), 4633–4640.
88. [88] Semitekolou, M., Alissafi, T., Aggelakopoulou, M., Kourepini, E., Kariyawasam, H.H., Kay, A.B., Robinson, D.S., Lloyd, C.M., Panoutsakopoulou, V., Xanthou, G., Activin-A induces regulatory T cells that suppress T helper cell immune responses and protect from allergic airway disease. J. Exp. Med. 206 (2009), 1769–1785.
89. [89] Nono, J.K., Pletinckx, K., Lutz, M.B., Brehm, K., Excretory/secretory-products of Echinococcus multilocularis larvae induce apoptosis and tolerogenic properties in dendritic cells in vitro. PLoS Negl. Trop. Dis., 6, 2012, e1516.
90. [90] Hartmann, W., Schramm, C., Breloer, M., Litomosoides sigmodontis induces TGF-β receptor responsive, IL-10-producing T cells that suppress bystander T-cell proliferation in mice. Eur. J. Immunol. 45 (2015), 2568–2581.
91. [91] Ren, P., Lim, C.-S., Johnsen, R.J., Albert, P.S., Pilgrim, D., Riddle, D.L., Control of C. elegans larval development by neuronal expression of a TGF-b homolog. Science 274 (1996), 1389–1391.
92. [92] Hotez, P., Hawdon, J., Schad, G.A., Hookworm larval infectivity, arrest and amphiparatenesis: the Caenorhabditis elegans Daf-c paradigm. Parasitol. Today 9 (1993), 23–26.
93. [93] Brand, A.M., Varghese, G., Majewski, W., Hawdon, J.M., Identification of a DAF-7 ortholog from the hookworm Ancylostoma caninum. Int. J. Parasitol. 35 (2005), 1489–1498.
94. [94] Crook, M., Thompson, F.J., Grant, W.N., Viney, M.E., Daf-7 and the development of Strongyloides ratti and Parastrongyloides trichosuri. Mol. Biochem. Parasitol. 139 (2005), 213–223.
95. [95] Freitas, T.C., Arasu, P., Cloning and characterisation of genes encoding two transforming growth factor-b-like ligands from the hookworm, Ancylostoma caninum. Int. J. Parasitol. 35 (2005), 1477–1487.
96. [96] Massey, H.C., Castelletto, M.L., Bhopale, V.M., Schad, G.A., Lok, J.B., Sst-tgh-1 from Strongyloides stercoralis encodes a proposed ortholog of daf-7 in Caenorhabditis elegans. Mol. Biochem. Parasitol. 142 (2005), 116–120.
97. [97] Viney, M.E., Thompson, F.J., Crook, M., TGF-beta and the evolution of nematode parasitism. Int. J. Parasitol. 35 (2005), 1473–1475.
98. [98] Freitas, T.C., Pearce, E.J., Growth factors and chemotactic factors from parasitic helminths: molecular evidence for roles in host-parasite interactions versus parasite development. Int. J. Parasitol. 40 (2010), 761–773.
99. [99] Japa, O., Hodgkinson, J.E., Emes, R.D., Flynn, R.J., TGF-β superfamily members from the helminth Fasciola hepatica show intrinsic effects on viability and development. Vet. Res., 46, 2015, 29.
100. [100] Koopman, P., Gubbay, J., Vivian, N., Goodfellow, P., Lovell-Badge, R., Male development of chromosomally female mice transgenic for Sry. Nature 351 (1991), 117–121.
101. [101] Dresser, D.W., Jamin, S.P., Atkins, C.J., Guerrier, D., An expressed GNRP-like gene shares a bi-directional promoter with SF3A2 (SAP62) immediately upstream of AMH. Gene 277 (2001), 163–173.
102. [102] Dresser, D.W., Mutated elements of a complex promoter (Amh) can help to demonstrate the role of certain elements in controlling differential gene expression. Am. J. Mol. Biol. 2 (2012), 351–358.
103. [103] Dresser, D.W., Interaction between the WIlns tumour factor-1 element in the promoter of Amh and a downstream enhancer is required for a strong expression of the gene in pre-pubertal sertoli cells. Am. J. Mol. Biol. 3 (2013), 165–172.
104. [104] Dresser, D.W., The transcription factors GATA-1 and GATA-4 have opposite effects on DNA expression driven by an Amh promoter. Am. J. Mol. Biol., 4, 2014.
105. [105] Dresser, D.W., Guerrier, D., Candidate Sertoli cell specific promoter element for a TGFbeta family member (Amh) and a 3′ UTR enhancer/repressor for the same gene. Gene 363 (2005), 159–165.
106. [106] Josso, N., Racine, C., di Clemente, N., Rey, R., Xavier, F., The role of anti-Müllerian hormone in gonadal development. Mol. Cell. Endocrinol. 145 (1998), 3–7.
107. [107] Owen, R.D., Immunogenetic consequences of vascular anastomoses between bovine twins. Science 102 (1945), 400–401.
108. [108] Weinstock, J.V., Autoimmunity: the worm returns. Nature 491 (2012), 183–185.
109. [109] Hartono, C., Muthukumar, T., Suthanthiran, M., Immunosuppressive drug therapy. Cold Spring Harbor Perspect. Med., 3, 2013, a015487.
110. [110] Elliott, D.E., Weinstock, J.V., Helminth-host immunological interactions: prevention and control of immune-mediated diseases. Ann. N. Y. Acad. Sci. 1247 (2012), 83–96.
111. [111] Quinnell, R.J., Genetics of susceptibility to human helminth infection. Int. J. Parasitol. 33 (2003), 1219–1231.
112. [112] Fleming, J.O., Weinstock, J.V., Clinical trials of helminth therapy in autoimmune diseases: rationale and findings. Parasite Immunol. 37 (2015), 277–292.
113. [113] H. Evans, E. Mitre, Worms as therapeutics for allergy: understanding why benefits in animal studies have not translated into clinical success, J. Allergy Clin. Immunol. (2014) (submitted).
114. [114] McSorley, H.J., Hewitson, J.P., Maizels, R.M., Immunomodulation by helminth parasites: defining mechanisms and mediators. Int. J. Parasitol. 43 (2013), 301–310.
115. [115] Delgoffe, G.M., Kole, T.P., Zheng, Y., Zarek, P.E., Matthews, K.L., Xiao, B., Worley, P.F., Kozma, S.C., Powell, J.D., The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30 (2009), 832–844.
116. [116] Benson, M.J., Pino-Lagos, K., Rosemblatt, M., Noelle, R.J., All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204 (2007), 1765–1774.
117. [117] Nolting, J., Daniel, C., Reuter, S., Stuelten, C., Li, P., Sucov, H., Kim, B.G., Letterio, J.J., Kretschmer, K., Kim, H.J., von Boehmer, H., Retinoic acid can enhance conversion of naive into regulatory T cells independently of secreted cytokines. J. Exp. Med. 206 (2009), 2131–2139.
118. [118] Kretschmer, K., Apostolou, I., Hawiger, D., Khazaie, K., Nussenzweig, M.C., von Boehmer, H., Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6 (2005), 1219–1227.
119. [119] Polansky, J.K., Kretschmer, K., Freyer, J., Floess, S., Garbe, A., Baron, U., Olek, S., Hamann, A., von Boehmer, H., Huehn, J., DNA methylation controls Foxp3 gene expression. Eur. J. Immunol. 38 (2008), 1654–1663.
120. [120] Sanchez-Fueyo, A., Weber, M., Domenig, C., Strom, T.B., Zheng, X.X., Tracking the immunoregulatory mechanisms active during allograft tolerance. J. Immunol. 168 (2002), 2274–2281.
121. + regulatory T lymphocytes. Nat. Med. 14 (2008), 88–92.
122. + regulatory T cells with indirect allospecificity and short term immunosuppression. Transpl. Immunol. 21 (2009), 203–209.
123. − T regulatory cells. Clin. Immunol. 133 (2009), 22–26.
124. [124] Edinger, M., Hoffmann, P., Regulatory T cells in stem cell transplantation: strategies and first clinical experiences. Curr. Opin. Immunol. 23 (2011), 679–684.
125. [125] Kim, Y.C., Zhang, A.H., Su, Y., Rieder, S.A., Rossi, R.J., Ettinger, R.A., Pratt, K.P., Shevach, E.M., Scott, D.W., Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T- and B-cell responses. Blood 125 (2015), 1107–1115.
126. [126] Juvet, S.C., Whatcott, A.G., Bushell, A.R., Wood, K.J., Harnessing regulatory T cells for clinical use in transplantation: the end of the beginning. Am. J. Transplant. 14 (2014), 750–763.
127. [127] van der Net, J.B., Bushell, A., Wood, K.J., Harden, P.N., Regulatory T cells: first steps of clinical application in solid organ transplantation. Transplant Int., 2015.
128. [128] Peters, J.H., Preijers, F.W., Woestenenk, R., Hilbrands, L.B., Koenen, H.J., Joosten, I., Clinical grade Treg: GMP isolation, improvement of purity by CD127 depletion, Treg expansion, and Treg cryopreservation. PLoS ONE, 3, 2008, e3161.
129. [129] Brunstein, C.G., Blazar, B.R., Miller, J.S., Cao, Q., Hippen, K.L., McKenna, D.H., Curtsinger, J., McGlave, P.B., Wagner, J.E., Adoptive transfer of umbilical cord blood-derived regulatory T cells and early viral reactivation. Biol. Blood Marrow Transplant. 19 (2013), 1271–1273.
130. [130] Floess, S., Freyer, J., Siewert, C., Baron, U., Olek, S., Polansky, J., Schlawe, K., Chang, H.-D., Bopp, T., Schmitt, E., Klein-Hessling, S., Serfling, E., Hamann, A., Huehn, J., Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol., 5, 2007, e38.
131. [131] McMurchy, A.N., Bushell, A., Levings, M.K., Wood, K.J., Moving to tolerance. clinical application of T regulatory cells. Semin. Immunol. 23 (2011), 304–313.
132. [132] Brunstein, C.G., Miller, J.S., Cao, Q., McKenna, D.H., Hippen, K.L., Curtsinger, J., Defor, T., Levine, B.L., June, C.H., Rubinstein, P., McGlave, P.B., Blazar, B.R., Wagner, J.E., Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 117 (2011), 1061–1070.
133. [133] Di Ianni, M., Falzetti, F., Carotti, A., Terenzi, A., Castellino, F., Bonifacio, E., Del Papa, B., Zei, T., Ostini, R.I., Cecchini, D., Aloisi, T., Perruccio, K., Ruggeri, L., Balucani, C., Pierini, A., Sportoletti, P., Aristei, C., Falini, B., Reisner, Y., Velardi, A., Aversa, F., Martelli, M.F., Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 117 (2011), 3921–3928.
134. − regulatory T cells preserves beta-cell function in type 1 diabetes in children. Diabetes Care 35 (2012), 1817–1820.
135. [135] Liu, R., Zhao, Q.P., Ye, Q., Xiong, T., Tang, C.L., Dong, H.F., Jiang, M.S., Cloning and characterization of a bone morphogenetic protein homologue of Schistosoma japonicum. Exp. Parasitol. 135 (2013), 64–71.
136. [136] Gomez-Escobar, N., van den Biggelaar, A., Maizels, R.M., A member of the TGF-β receptor gene family in the parasitic nematode Brugia. Gene 199 (1997), 101–109.
137. [137] Zavala-Gongora, R., Kroner, A., Bernthaler, P., Knaus, P., Brehm, K., A member of the transforming growth factor-b receptor family from Echinococcus multilocularis is activated by human bone morphogenetic protein 2. Mol. Biochem. Parasitol. 146 (2006), 265–271.
138. [138] Beall, M.J., Pearce, E.J., Human transforming growth factor-β activates a receptor serine/threonine kinase from the intravascular parasite Schistosoma mansoni. J. Biol. Chem. 276 (2001), 31613–31619.
139. [139] Forrester, S.G., Warfel, P.W., Pearce, E.J., Tegumental expression of a novel type II receptor serine/threonine kinase (SmRK2) in Schistosoma mansoni. Mol. Biochem. Parasitol. 136 (2004), 149–156.
140. [140] Osman, A., Niles, E.G., Verjovski-Almeida, S., LoVerde, P.T., Schistosoma mansoni TGF-b receptor II: role in host ligand-induced regulation of a schistosome target gene. PLoS Pathog., 2, 2006, e54.
141. [141] Zavala-Gongora, R., Kroner, A., Wittek, B., Knaus, P., Brehm, K., Identification and characterisation of two distinct Smad proteins from the fox-tapeworm Echinococcus multilocularis. Int. J. Parasitol. 33 (2003), 1665–1677.
142. [142] Zavala-Gongora, R., Derrer, B., Gelmedin, V., Knaus, P., Brehm, K., Molecular characterisation of a second structurally unusual AR-Smad without an MH1 domain and a Smad4 orthologue from Echinococcus multilocularis. Int. J. Parasitol. 38 (2008), 161–176.
143. [143] Epping, K., Brehm, K., Echinococcus multilocularis: molecular characterization of EmSmadE, a novel BR-Smad involved in TGF-beta and BMP signaling. Exp. Parasitol. 129 (2011), 85–94.
144. [144] Osman, A., Niles, E.G., LoVerde, P.T., Identification and characterization of a Smad2 homologue from Schistosoma mansoni, a transforming growth factor-beta signal transducer. J. Biol. Chem. 276 (2001), 10072–10082.
145. [145] Osman, A., Niles, E.G., LoVerde, P.T., Expression of functional Schistosoma mansoni Smad4: role in Erk-mediated transforming growth factor beta (TGF-beta) down-regulation. J. Biol. Chem. 279 (2004), 6474–6486.